Skip to main content
Premium Trial:

Request an Annual Quote

Novo Nordisk to Use Linguamatics Text Mining Platform

NEW YORK (GenomeWeb News) – Linguamatics today said that the diabetes care company Novo Nordisk will use its text mining and natural language processing software.

Under a multi-year agreement, the Cambridge, UK-based company said that Novo Nordisk will use its I2E to mine published literature and internal information sources to provide intelligence for making research and development decisions. Linguamatics COO Roger Hale said in a statement that the I2E platform can be used to "deliver value for questions ranging from R&D to business and competitor intelligence."

The software is used for a variety of applications, including in biomarker discovery, pharmacogenomics, target selection, systems biology, and toxicology.

Financial terms of the agreement were not disclosed.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.